These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 29247817)

  • 1. Generation of a PXR reporter human induced pluripotent stem cell line (PXR-mCherry hiPSC) using the CRISPR/Cas9 system.
    Kim H; Kim JW; Kim SJ; Choi YJ; Kim DS; Park HJ
    Stem Cell Res; 2018 Jan; 26():72-75. PubMed ID: 29247817
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Live-cell screening platform using human-induced pluripotent stem cells expressing fluorescence-tagged cytochrome P450 1A1.
    Kim JW; Im I; Kim H; Jeon JS; Kang EH; Jo S; Chun HS; Yoon S; Kim JH; Kim SK; Park HJ
    FASEB J; 2020 Jul; 34(7):9141-9155. PubMed ID: 32421247
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human Induced Pluripotent Stem Cell NEUROG2 Dual Knockin Reporter Lines Generated by the CRISPR/Cas9 System.
    Li S; Xue H; Wu J; Rao MS; Kim DH; Deng W; Liu Y
    Stem Cells Dev; 2015 Dec; 24(24):2925-42. PubMed ID: 26414932
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Generation of a NESTIN-EGFP reporter human induced pluripotent stem cell line, KSCBi005-A-1, using CRISPR/Cas9 nuclease.
    Lee Y; Choi HY; Kwon A; Park H; Park M; Kim YO; Kwak S; Koo SK
    Stem Cell Res; 2019 Oct; 40():101554. PubMed ID: 31499408
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Embryonic or Induced Pluripotent Stem Cell-Derived Hepatocellular Systems for HCV Culture.
    Wu X; Dao Thi VL
    Methods Mol Biol; 2019; 1911():121-135. PubMed ID: 30593622
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Generation of Brachyury-mCherry knock-in reporter human pluripotent stem cell line (SNUe003-A-2) using CRISPR/CAS9 nuclease.
    Jung J; Hwang S; Seol H; Kim AH; Lee HM; Sung JJ; Jeong SM; Choi YM; Jun JK; Kim DW; Jang J
    Stem Cell Res; 2021 May; 53():102321. PubMed ID: 33878708
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Generation of metabolically functioning hepatocytes from human pluripotent stem cells by FOXA2 and HNF1α transduction.
    Takayama K; Inamura M; Kawabata K; Sugawara M; Kikuchi K; Higuchi M; Nagamoto Y; Watanabe H; Tashiro K; Sakurai F; Hayakawa T; Furue MK; Mizuguchi H
    J Hepatol; 2012 Sep; 57(3):628-36. PubMed ID: 22659344
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Generation of a SOX2 reporter human induced pluripotent stem cell line using CRISPR/SaCas9.
    Balboa D; Weltner J; Novik Y; Eurola S; Wartiovaara K; Otonkoski T
    Stem Cell Res; 2017 Jul; 22():16-19. PubMed ID: 28952927
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Generation of an OCT4 reporter human induced pluripotent stem cell line using CRISPR/SpCas9.
    Balboa D; Weltner J; Novik Y; Eurola S; Wartiovaara K; Otonkoski T
    Stem Cell Res; 2017 Aug; 23():105-108. PubMed ID: 28925359
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Generation of a TLR7 homozygous knockout human induced pluripotent stem cell line using CRISPR/Cas9.
    Han HJ; Seo HH; Han HW; Kim JH
    Stem Cell Res; 2019 Oct; 40():101520. PubMed ID: 31445394
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Generation of a human iPSC line CIBi010-A with a reporter for ASGR1 using CRISPR/Cas9.
    Fu J; Jiang L; Yu B; Liu Y; Wei R; Hu Y; Ho WI; Yang B; Chu M; Tse HF; Yang J
    Stem Cell Res; 2022 Jul; 62():102800. PubMed ID: 35561459
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug metabolizing enzyme and transporter protein profiles of hepatocytes derived from human embryonic and induced pluripotent stem cells.
    Ulvestad M; Nordell P; Asplund A; Rehnström M; Jacobsson S; Holmgren G; Davidson L; Brolén G; Edsbagge J; Björquist P; Küppers-Munther B; Andersson TB
    Biochem Pharmacol; 2013 Sep; 86(5):691-702. PubMed ID: 23856292
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Generation of green fluorescent protein reporter knock-in iPSC line at the 3'UTR region of the KLOTHO locus.
    Lim SW; Lee KI; Cui S; Fang X; Shin YJ; Lee H; Lee JY; Chung BH; Yang CW
    Stem Cell Res; 2024 Oct; 80():103499. PubMed ID: 39111000
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Generation and characterization of GATA6-specific EGFP expressing human induced pluripotent stem cell line, KSCBi017-A-1, using CRISPR/Cas9.
    Bayarsaikhan D; Yoo DH; Lee J; Im YS; Bayarsaikhan G; Kang HA; Kim YO; Lee B
    Stem Cell Res; 2024 Jun; 77():103426. PubMed ID: 38678980
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reversal of Phenotypic Abnormalities by CRISPR/Cas9-Mediated Gene Correction in Huntington Disease Patient-Derived Induced Pluripotent Stem Cells.
    Xu X; Tay Y; Sim B; Yoon SI; Huang Y; Ooi J; Utami KH; Ziaei A; Ng B; Radulescu C; Low D; Ng AYJ; Loh M; Venkatesh B; Ginhoux F; Augustine GJ; Pouladi MA
    Stem Cell Reports; 2017 Mar; 8(3):619-633. PubMed ID: 28238795
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Generation and Characterization of a MYF5 Reporter Human iPS Cell Line Using CRISPR/Cas9 Mediated Homologous Recombination.
    Wu J; Hunt SD; Xue H; Liu Y; Darabi R
    Sci Rep; 2016 Jan; 6():18759. PubMed ID: 26729410
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Generation of a PPM1A-deficient human induced pluripotent stem cell line using CRISPR-Cas9 technology.
    Guo X; Zhao K; Zhang Y; Zhou T; Pan G
    Stem Cell Res; 2024 Jun; 77():103420. PubMed ID: 38643711
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CRISPR/Cas9-mediated suppression of A4GALT rescues endothelial cell dysfunction in a fabry disease vasculopathy model derived from human induced pluripotent stem cells.
    Shin YJ; Chae SY; Lee H; Fang X; Cui S; Lim SW; Lee KI; Lee JY; Li C; Yang CW; Chung BH
    Atherosclerosis; 2024 Oct; 397():118549. PubMed ID: 39141976
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Generation of 'designer erythroblasts' lacking one or more blood group systems from CRISPR/Cas9 gene-edited human-induced pluripotent stem cells.
    Pandey P; Zhang N; Curtis BR; Newman PJ; Denomme GA
    J Cell Mol Med; 2021 Oct; 25(19):9340-9349. PubMed ID: 34547166
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Generation of a CLTA reporter human induced pluripotent stem cell line, CRMi001-A-1, using the CRISPR/Cas9 system to monitor endogenous clathrin trafficking.
    Anderson RH; Kerkvliet JG; Otta JJ; Ross AD; Leiferman PC; Hoppe AD; Francis KR
    Stem Cell Res; 2018 Dec; 33():95-99. PubMed ID: 30340091
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.